News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant
September 3, 2025
·
9 min read
Press Releases
Scryb Reports Financial Results for Q3 2025: Positive Outlook for Cybeats Technologies Corp.
September 3, 2025
·
1 min read
Press Releases
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 3, 2025
·
4 min read
Press Releases
American Aires Inc. Announces Business Continuity and Governance Actions Following Special Committee Review
September 2, 2025
·
7 min read
Press Releases
Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth
September 2, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
September 2, 2025
·
10 min read
Press Releases
Aires Announces Record Q2 2025 Revenue of $6.0 Million & 115% YoY Sales Growth
September 2, 2025
·
12 min read
Press Releases
Soricimed Biopharma Inc. Strengthens Executive Team with Appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer
September 2, 2025
·
3 min read
Press Releases
OS Therapies Completes Exercise Inducement and Exchange Offer for All Remaining Outstanding Warrants Issued in Connection with December 2024 Financing
September 2, 2025
·
5 min read
Press Releases
OS Therapies Provides OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma Program Update Following FDA End of Phase 2 Meeting
September 2, 2025
·
9 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us